Commentary: Big Pharma is wrong. Allowing Medicare to negotiate drug prices won’t hinder new cures

Big Pharma is pulling out all the stops to avoid lowering drug prices for seniors.

Several pharmaceutical companies, including Merck, Johnson & Johnson and Bristol Myers Squibb; the key pharma lobbying group Pharmaceutical Research and Manufacturers of America (PhRMA); and the U.S. Chamber of Commerce have recently filed lawsuits against President Joe Biden’s administration, arguing that the Inflation Reduction Act provision that allows Medicare to negotiate drug prices with pharmaceutical companies is unconstitutional.

Their legal strategy is tantamount to “throwing the kitchen sink at the government,” as one expert described it, with various lawsuits arguing violations to the First, Fifth,